Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Pancreatic beta-cell glucose toxicity and mRNA translation

Award Number: K99DK140526
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 08/01/2024
PERIOD OF PERFORMANCE END DATE: 07/31/2026

Group Awards By:

View Award Description

Pancreatic beta-cell glucose toxicity and mRNA translation - ABSTRACT Pancreatic β-cells are specialized to carry out high capacity mRNA translation that is tightly regulated by the nutrient environment. However, these features expose β-cells to several vulnerabilities, including deleterious endoplasmic reticulum stress and translation errors that can can result in production of defective ribosome products (DRIPs), which have been implicated in autoimmunity in type 1 diabetes (T1D). Whereas, acute glucose exposure robustly increases translation of insulin and other secretory granule proteins, chronic high glucose decreases insulin translation and secretion even prior to impact on global translation or upregulation of endoplasmic reticulum stress. To determine the extent of translational changes at this early stage of β-cell dysfunction, I used ribosome profiling and nascent proteomics in MIN6 insulinoma cells to elucidate the genome- wide impact of sustained high glucose on β-cell mRNA translation. Sustained high glucose conditions that suppressed insulin secretion downregulated translation of insulin and proteins, such as SCGN, IDH2, VPS41, SLC2A2, IGF2, SLC30A8 and PFKFB3, which are involved in insulin secretory granule formation, exocytosis, and metabolism-coupled insulin secretion. Translation of these mRNAs was also downregulated in primary rat and human islets following ex-vivo incubation with chronic high glucose, and in an in vivo partial pancreatectomy model of chronic hyperglycemia. Translational downregulation decreased cellular abundance of these proteins. Subsequent analysis of actively translating ribosomes and pathways that regulate mRNA quality during translation showed that sustained high glucose changes the protein composition of translating ribosomes and suppresses nonsense mediated RNA decay (NMD). Altered ribosome composition and activity of RNA decay pathways could result in changes in the abundance and fidelity of the proteins produced. I hypothesize that hyperglycemia-induced remodeling of ribosomes and suppression of NMD alter expression of key β-cell genes and increase neo-antigen production. In this proposal I will investigate the extent to which sustained high glucose-remodeled ribosomes contribute to dysregulation of mRNA translation in β-cells and determine the impact of reduced RNA surveillance and altered translation on neoantigen production and autoimmunity in T1D. These studies could uncover novel therapeutic targets for prevention of progressive β-cell failure in T1D and for optimizing functionality of ex vivo generated β-cells for cell replacement therapy.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $90,000 )
2025	2025	JOSLIN DIABETES CENTER, INC.	1 JOSLIN PL	BOSTON	MA	02215	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	8/12/2025	NON-COMPETING CONTINUATION	$90,000
														Subtotal = $90,000

Issue Date FY: 2024 ( Subtotal = $91,500 )
2024	2024	JOSLIN DIABETES CENTER, INC.	1 JOSLIN PL	BOSTON	MA	02215	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	7/26/2024	NEW	$91,500
														Subtotal = $91,500

Grand Total All Awards = $181,500

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Pancreatic beta-cell glucose toxicity and mRNA translation

Award Number: K99DK140526

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 08/01/2024

PERIOD OF PERFORMANCE END DATE: 07/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer